Trial Profile
A Pharmacokinetic Interaction Study Evaluating the Effect of Repeated Retigabine Dosing on thePharmacokinetics of Oral Contraceptives in Healthy Adult Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jul 2023
Price :
$35
*
At a glance
- Drugs Retigabine (Primary) ; Ethinylestradiol/norethisterone
- Indications Partial epilepsies
- Focus Pharmacokinetics
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 28 Apr 2014 New trial record